Psoralidin, an isoflavone, promotes calcium nodule formation, ALP activity, and osteocalcin levels in MC3T3-E1 cells, suggesting its potential in bone formation promotion and osteoporosis treatment (Cao et al., 2019). This evidence concerns the gene BGLAP and osteoporosis.